암생검 시장 : 제품별, 생검 유형별 - 시장 규모, 점유율, 전망, 기회 분석(2023-2030년)
Cancer Biopsy Market, By Product, Biopsy Type (((Tissue Biopsy (Needle Biopsy, Liquid Biopsy, and Others))), and By Application By Geography )- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
상품코드
:
1330119
리서치사
:
Coherent Market Insights
발행일
:
2023년 06월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
생검은 체내의 조직 및 세포 샘플을 채취하여 실험실에서 검사하는 의학 검사입니다. 한편, 암생검은 암의 존재, 원인 및 정도를 발견하기 위해 암에 걸린 환자의 조직과 세포를 채취하는 것입니다. 이처럼 세계에서 암의 부담이 증가함에 따라 암생검의 사용도 빠른 속도로 증가하고 있습니다.
시장 역학 :
종양성 질환의 유병률 증가, 노령 인구 증가, 액체생검의 등장 및 채택 증가, 유전자 검사 및 유전성 종양 질환에 대한 사람들의 인식 증가, 생검 기술의 지속적인 개발은 세계 암생검 시장의 성장을 증가시킬 것으로 예상되는 주요 요인입니다.
본 조사의 주요 특징
- 이 보고서는 2022년을 기준연도로 하여 예측 기간(2023-2030년) 시장 규모와 연평균 성장률(CAGR)을 제공하는 세계 암생검 시장을 상세하게 분석합니다.
- 또한 다양한 부문의 잠재적 매출 기회를 파악하고 이 시장에 대한 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략 등에 대한 중요한 고려 사항도 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략과 같은 다음 매개 변수를 기반으로 세계 암생검 시장의 주요 기업을 프로파일링합니다.
- 이 조사 대상의 주요 기업으로는 QIAGEN, Illumina, Inc. Danaher, F. Hoffmann-La Roche Ltd., Epigenomics AG, BD(Becton, Dickinson and Company), Helio Health(Laboratory for Advanced Medicine) 등이 포함됩니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대 및 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 이 조사 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자는 세계 암생검 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 개요
- 리포트 개요
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 암질환 부담 증가
- 기술적 및 임상적 과제
- 액체생검 도입의 증가
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter의 산업 분석
- 합병·인수 시나리오
제4장 세계의 암생검 시장 - 코로나바이러스(COVID-19) 유행의 영향
- COVID-19 역학
- 공급측과 수요측 분석
- 경제적 영향
제5장 세계의 암생검 시장 : 제품별, 2023-2030년
제6장 세계의 암생검 시장 : 생검 유형별, 2023-2030년
제7장 세계의 암생검 시장 : 용도별, 2023-2030년
- 유방암
- 대장암
- 자궁경부암
- 폐암
- 전립선암
- 피부암
- 혈액암
- 신장암
- 간암
- 췌장암
- 난소암
- 기타
제8장 세계의 암생검 시장 : 지역별, 2023-2030년
제9장 경쟁 구도
- QIAGEN
- Illumina, Inc.
- Angle PLC
- Myriad Genetics
- COUNSYL, Inc.
- Hologic, Inc.
- Biocept, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher
- F. Hoffmann-La Roche Ltd.
- Epigenomics AG
- BD(Becton, Dickinson and Company)
- Helio Health(Laboratory for Advanced Medicine)
제10장 섹션
KSA
영문 목차
A biopsy is a medical test to remove the piece of tissue or a sample of cells from the body so that it can be tested in a laboratory. While, in cancer biopsy, a tissue or cells of the affected patient is taken to discover the presence, cause, or extent of cancer. Thus, with the rising burden of cancer across the globe, the use of cancer biopsy or cancer biopsies also increasing with a rapid pace.
Market Dynamics:
Increasing prevalence of oncology disorders, growing geriatric population, advent of liquid biopsy or increasing adoption of liquid biopsies, increasing awareness among people about genetic testing and inherited oncology diseases, and ongoing developments in biopsy techniques are major factors expected to augment the growth of the global cancer biopsy market.
For instance, in May 2022, Delfi Diagnostics, a developer of a new class of high-performance and affordable liquid biopsy tests for early cancer detection, presented multiple applications for its next-generation liquid biopsy platform. Delfi presented a trial-in-progress update on DELFI-L101, a prospective, case-control study to train and test classifiers for lung cancer detection.
Key features of the study:
- This report provides in-depth analysis of the global cancer biopsy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global cancer biopsy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include QIAGEN, Illumina, Inc., Angle PLC, Myriad Genetics, COUNSYL, Inc., Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher, F. Hoffmann-La Roche Ltd., Epigenomics AG, BD (Becton, Dickinson and Company), and Helio Health (Laboratory for Advanced Medicine), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global cancer biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer biopsy market.
Detailed Segmentation:
- Global Cancer Biopsy Market , By Product:
- Instruments
- Kits and Consumables
- Services
- Global Cancer Biopsy Market , By Biopsy Type:
- Tissue Biopsy
- Fine Needle Aspiration (FNA)
- Core Needle Biopsy (CNB)
- Liquid Biopsy
- Others
- Global Cancer Biopsy Market, By Application:
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Lung Cancer
- Prostate Cancer
- Skin Cancer
- Blood Cancer
- Kidney Cancer
- Liver Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Others
- Global Cancer Biopsy Market , By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles:
- QIAGEN
- Illumina, Inc.
- Angle PLC
- Myriad Genetics
- COUNSYL, Inc.
- Hologic, Inc.
- Biocept, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher
- F.Hoffmann-La Roche Ltd.
- Epigenomics AG
- BD (Becton, Dickinson and Company)
- Helio Health (Laboratory for Advanced Medicine)
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Biopsy Type
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising burden of oncology disorders
- Technical and clinical challenges
- Increasing adoption of liquid biopsies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Cancer Biopsy Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Cancer Biopsy Market, By Product, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Kits and Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Cancer Biopsy Market, By Biopsy Type, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Tissue Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Needle Biopsy
- Fine Needle Aspiration (FNA)
- Core Needle Biopsy (CNB)
- Liquid Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
7. Global Cancer Biopsy Market, By Application, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Cervical Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Skin Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Blood Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Kidney Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Pancreatic Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Ovarian Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
8. Global Cancer Biopsy Market, By Region, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
9. Competitive Landscape
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina, Inc.
- Angle PLC
- Myriad Genetics
- COUNSYL, Inc.
- Hologic, Inc.
- Biocept, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher
- F. Hoffmann-La Roche Ltd.
- Epigenomics AG
- BD (Becton, Dickinson and Company)
- Helio Health (Laboratory for Advanced Medicine)
- Analyst Views
10. Section
- Research Methodology
- About us
관련자료
